New CAR T-Cell Immunotherapy Approaches to Solid Tumors in Children

The STRIvE-01 study explored the safety of CAR T-cell therapy in children and young adults with relapsed or refractory solid tumors.

Source: CancerNetwork - August 15, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news